109 related articles for article (PubMed ID: 31545289)
21. High miR-139-3p expression predicts a better prognosis for hepatocellular carcinoma: a pooled analysis.
Zhu Y; Zhou C; He Q
J Int Med Res; 2019 Jan; 47(1):383-390. PubMed ID: 30394818
[TBL] [Abstract][Full Text] [Related]
22. [Influence of UCHL5 on proliferation and apoptosis of SW527 breast cancer cells].
Ding F; Ma JL; Wu XW; Liu ZH
Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):900-904. PubMed ID: 30605979
[No Abstract] [Full Text] [Related]
23. The transcriptional STAT3 is a potential target, whereas transcriptional STAT5A/5B/6 are new biomarkers for prognosis in human breast carcinoma.
Wu HT; Liu J; Li GW; Shen JX; Huang YT
Oncotarget; 2017 May; 8(22):36279-36288. PubMed ID: 28422733
[TBL] [Abstract][Full Text] [Related]
24. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
Ma D; Chen C; Wu J; Wang H; Wu D
Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352
[TBL] [Abstract][Full Text] [Related]
25. Expression of LPA2 is associated with poor prognosis in human breast cancer and regulates HIF-1α expression and breast cancer cell growth.
Li M; Xiao D; Zhang J; Qu H; Yang Y; Yan Y; Liu X; Wang J; Liu L; Wang J; Duan X
Oncol Rep; 2016 Dec; 36(6):3479-3487. PubMed ID: 27805252
[TBL] [Abstract][Full Text] [Related]
26. Long Non-Coding RNA TFAP2A-AS1 Inhibits Cell Proliferation and Invasion in Breast Cancer via miR-933/SMAD2.
Zhou B; Guo H; Tang J
Med Sci Monit; 2019 Feb; 25():1242-1253. PubMed ID: 30768589
[TBL] [Abstract][Full Text] [Related]
27. TP73-AS1 promotes breast cancer cell proliferation through miR-200a-mediated TFAM inhibition.
Yao J; Xu F; Zhang D; Yi W; Chen X; Chen G; Zhou E
J Cell Biochem; 2018 Jan; 119(1):680-690. PubMed ID: 28639399
[TBL] [Abstract][Full Text] [Related]
28. The Clinicopathological Significance and Correlative Signaling Pathways of an Autophagy-Related Gene, Ambra1, in Breast Cancer: a Study of 25 Microarray RNA-Seq Datasets and in-House Gene Silencing.
He RQ; Xiong DD; Ma J; Hu XH; Chen G; Sun WL
Cell Physiol Biochem; 2018; 51(3):1027-1040. PubMed ID: 30476925
[TBL] [Abstract][Full Text] [Related]
29. Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer.
Chen M; Zhang H; Zhang G; Zhong A; Ma Q; Kai J; Tong Y; Xie S; Wang Y; Zheng H; Guo L; Lu R
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):74-82. PubMed ID: 30454896
[TBL] [Abstract][Full Text] [Related]
30. Increased Expression of Circular RNA circ_0005230 Indicates Dismal Prognosis in Breast Cancer and Regulates Cell Proliferation and Invasion via miR-618/ CBX8 Signal Pathway.
Xu Y; Yao Y; Leng K; Ji D; Qu L; Liu Y; Cui Y
Cell Physiol Biochem; 2018; 51(4):1710-1722. PubMed ID: 30504704
[TBL] [Abstract][Full Text] [Related]
31. Analysis of high fat diet induced genes during mammary gland development: identifying role players in poor prognosis of breast cancer.
Martinez-Chacin RC; Keniry M; Dearth RK
BMC Res Notes; 2014 Aug; 7():543. PubMed ID: 25134718
[TBL] [Abstract][Full Text] [Related]
32. Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer.
Xu JH; Wang Y; Xu D
Cancer Biomark; 2019; 25(2):193-201. PubMed ID: 31104012
[TBL] [Abstract][Full Text] [Related]
33. Elevated HMGA2 expression is associated with cancer aggressiveness and predicts poor outcome in breast cancer.
Wu J; Zhang S; Shan J; Hu Z; Liu X; Chen L; Ren X; Yao L; Sheng H; Li L; Ann D; Yen Y; Wang J; Wang X
Cancer Lett; 2016 Jul; 376(2):284-92. PubMed ID: 27063096
[TBL] [Abstract][Full Text] [Related]
34. Transcriptome analysis of luminal breast cancer reveals a role for LOL in tumor progression and tamoxifen resistance.
Sun W; Xu X; Jiang Y; Jin X; Zhou P; Liu Y; Guo Y; Ma D; Zuo W; Huang S; He X; Shao Z
Int J Cancer; 2019 Aug; 145(3):842-856. PubMed ID: 30720865
[TBL] [Abstract][Full Text] [Related]
35. The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression.
Lo PK; Lee JS; Liang X; Sukumar S
Cell Signal; 2016 Oct; 28(10):1502-19. PubMed ID: 27377963
[TBL] [Abstract][Full Text] [Related]
36. Prospective molecular mechanism of COL5A1 in breast cancer based on a microarray, RNA sequencing and immunohistochemistry.
Wu M; Sun Q; Mo CH; Pang JS; Hou JY; Pang LL; Lu HP; Dang YW; Fang SJ; Tang D; Chen G; Feng ZB
Oncol Rep; 2019 Jul; 42(1):151-175. PubMed ID: 31059074
[TBL] [Abstract][Full Text] [Related]
37. The enigmatic oncogene and tumor suppressor-like properties of RAD54B: Insights into genome instability and cancer.
McAndrew EN; McManus KJ
Genes Chromosomes Cancer; 2017 Jul; 56(7):513-523. PubMed ID: 28295846
[TBL] [Abstract][Full Text] [Related]
38. Loss of heterozygosity in the RAD54B region is not predictive for breast carcinomas.
Bryś M; Nowacka-Zawisza M; Romanowicz-Makowska H; Zadrozny M; Kulig A; Krajewska WM
Pol J Pathol; 2007; 58(1):3-6. PubMed ID: 17585536
[TBL] [Abstract][Full Text] [Related]
39. The BMP inhibitor DAND5 in serum predicts poor survival in breast cancer.
Chi Y; Yao L; Hu X; Huang S; Huang N; Li S; Shao Z; Wu J
Oncotarget; 2016 Mar; 7(12):14951-62. PubMed ID: 26908452
[TBL] [Abstract][Full Text] [Related]
40. Specific synthetic lethal killing of RAD54B-deficient human colorectal cancer cells by FEN1 silencing.
McManus KJ; Barrett IJ; Nouhi Y; Hieter P
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3276-81. PubMed ID: 19218431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]